vs
Side-by-side financial comparison of Good Times Restaurants Inc. (GTIM) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $32.7M, roughly 1.5× Good Times Restaurants Inc.). Good Times Restaurants Inc. runs the higher net margin — 0.6% vs -4.8%, a 5.3% gap on every dollar of revenue. On growth, Good Times Restaurants Inc. posted the faster year-over-year revenue change (-10.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $1.2M). Over the past eight quarters, Good Times Restaurants Inc.'s revenue compounded faster (-0.7% CAGR vs -20.2%).
Good Times is a Golden, Colorado–based fast-food restaurant specializing in premium burgers and frozen custard. As of July 2023, the chain operates 31 locations, down from 38 in 2015.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
GTIM vs IRWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.7M | $47.7M |
| Net Profit | $181.0K | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 0.9% | 14.3% |
| Net Margin | 0.6% | -4.8% |
| Revenue YoY | -10.0% | -47.3% |
| Net Profit YoY | 10.4% | -200.9% |
| EPS (diluted) | $0.02 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.7M | $47.7M | ||
| Q3 25 | $37.0M | $122.1M | ||
| Q2 25 | $34.3M | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $36.3M | $90.5M | ||
| Q3 24 | $35.8M | $91.6M | ||
| Q2 24 | $38.0M | $94.4M | ||
| Q1 24 | $35.4M | $74.9M |
| Q4 25 | $181.0K | $-2.3M | ||
| Q3 25 | $1.5M | $40.1M | ||
| Q2 25 | $-624.0K | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | $164.0K | $2.3M | ||
| Q3 24 | $230.0K | $3.6M | ||
| Q2 24 | $1.3M | $-860.0K | ||
| Q1 24 | $618.0K | $-4.2M |
| Q4 25 | 0.9% | 14.3% | ||
| Q3 25 | 3.3% | 61.8% | ||
| Q2 25 | -1.5% | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | 0.2% | 34.8% | ||
| Q3 24 | -0.3% | 28.0% | ||
| Q2 24 | 3.2% | 26.5% | ||
| Q1 24 | 1.8% | 14.7% |
| Q4 25 | 0.6% | -4.8% | ||
| Q3 25 | 4.0% | 32.8% | ||
| Q2 25 | -1.8% | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | 0.5% | 2.5% | ||
| Q3 24 | 0.6% | 4.0% | ||
| Q2 24 | 3.5% | -0.9% | ||
| Q1 24 | 1.7% | -5.6% |
| Q4 25 | $0.02 | $0.01 | ||
| Q3 25 | $0.14 | $0.23 | ||
| Q2 25 | $-0.06 | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | $0.02 | $0.03 | ||
| Q3 24 | $0.01 | $0.02 | ||
| Q2 24 | $0.12 | $-0.01 | ||
| Q1 24 | $0.06 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $33.2M | $-261.8M |
| Total Assets | $82.5M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | $2.7M | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | $3.0M | $88.6M | ||
| Q3 24 | $3.9M | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | $4.0M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $33.2M | $-261.8M | ||
| Q3 25 | $33.1M | $-264.2M | ||
| Q2 25 | $31.6M | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | $32.4M | $-301.3M | ||
| Q3 24 | $32.4M | $-311.3M | ||
| Q2 24 | $32.3M | $-321.7M | ||
| Q1 24 | $31.6M | $-330.5M |
| Q4 25 | $82.5M | $396.9M | ||
| Q3 25 | $85.8M | $396.1M | ||
| Q2 25 | $86.9M | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | $89.5M | $350.9M | ||
| Q3 24 | $87.1M | $389.5M | ||
| Q2 24 | $90.1M | $395.6M | ||
| Q1 24 | $89.0M | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.4M | $74.6M |
| Free Cash FlowOCF − Capex | $1.2M | $74.6M |
| FCF MarginFCF / Revenue | 3.8% | 156.3% |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.85× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-72.0K | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4M | $74.6M | ||
| Q3 25 | $1.3M | $47.6M | ||
| Q2 25 | $714.0K | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | $-518.0K | $15.2M | ||
| Q3 24 | $394.0K | $9.9M | ||
| Q2 24 | $3.2M | $33.5M | ||
| Q1 24 | $1.8M | $45.0M |
| Q4 25 | $1.2M | $74.6M | ||
| Q3 25 | $735.0K | $47.6M | ||
| Q2 25 | $-105.0K | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-466.0K | $9.9M | ||
| Q2 24 | $2.0M | $33.4M | ||
| Q1 24 | $1.2M | $44.9M |
| Q4 25 | 3.8% | 156.3% | ||
| Q3 25 | 2.0% | 39.0% | ||
| Q2 25 | -0.3% | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | -5.3% | — | ||
| Q3 24 | -1.3% | 10.8% | ||
| Q2 24 | 5.3% | 35.4% | ||
| Q1 24 | 3.2% | 60.0% |
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 2.4% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 3.9% | 0.0% | ||
| Q3 24 | 2.4% | 0.0% | ||
| Q2 24 | 3.2% | 0.1% | ||
| Q1 24 | 1.7% | 0.1% |
| Q4 25 | 7.85× | — | ||
| Q3 25 | 0.85× | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.16× | 6.74× | ||
| Q3 24 | 1.71× | 2.71× | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 2.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
